Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 03, 2017 | Chief Science Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 70,621 | -- | 70,621 | |
| Nov 01, 2016 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 25,000 | $7.00 | 533,453 | |
| Oct 03, 2016 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 25,000 | $7.25 | 558,453 | |
| Sep 06, 2016 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 25,000 | $7.00 | 583,453 | |
| Aug 04, 2016 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 25,000 | $7.00 | 608,453 | |
| Jun 15, 2016 | Chief Science Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 12,500 | -- | 633,453 | |
| Jun 15, 2016 | Chief Science Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 50,000 | -- | 50,000 | |
| Jan 04, 2016 | Chief Science Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 75,000 | -- | 75,000 | |
| Nov 20, 2015 | Chief Science Officer | Bona fide gift | Form 5 | 100,000 | -- | 620,953 | |
| Sep 15, 2015 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 25,000 | $17.75 | 720,953 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.